STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE ORIGINS OF THE SELECTIVITY OF SELADELPAR AND ELAFIBRANOR, PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR (PPAR) AGONISTS TARGETING INFLAMMATORY LIVER DISEASES

Song, JG; Stebbins, J; Choi, YJ; Johnson, J; Cable, E; McWherter, C

HEPATOLOGY, 2019; 70 (): 1327A